Icon has purchased a clinical research oraganization (CRO)- BeijingWits Medical Consulting to strengthen its presence and capabilities in China.
BeijingWits provides full-service clinical development capabilities and also executes clinical trial in China.
Icon CEO Ciaran Murray said BeijingWits brings to ICON a strong leadership team, experienced staff and good relationships with local investigator sites and regulatory bodies.
BeijingWits Medical Consulting general manager and founder Yan Bin Xie said by combining their local knowledge with ICON’s global infrastructure and experience will offer clients a formula for successful clinical development.
"ICON has strong growth plans for China and Asia-Pacific and we look forward to playing a leading role in helping them achieve these goals," Xie said.